Oncobox

Oncobox, originally known as OncoBox, is a healthcare diagnostics company located in Walnut, California. Established in 2017 and part of Y Combinator’s S17 batch, Oncobox operates primarily in the United States and Canada. The company focuses on analyzing tumor DNA, RNA, and molecular pathways through advanced algorithms to pinpoint critical molecular targets for individual cancer cases. This process facilitates the creation of clinically actionable reports, aiding physicians in selecting the most effective drugs for their patients. A notable study involving 900 patients demonstrated that Oncobox’s approach increased the effectiveness of targeted cancer therapies from 25% to 64%. With a compact team of 11 professionals, Oncobox seeks collaboration with pharmaceutical companies, hospitals, clinicians, payers, and genomic centers to further its mission in the field of oncology and drug discovery.